Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer’s Type in Rats
- 12 Downloads
Alzheimer’s disease (AD) is the most common cause of progressive decline of memory function in aged humans. To study about a disease mechanism and progression, animal models for the specific disease are needed. For AD, although highly valid animal models exist, none of the existing models recapitulates all aspects of human AD. The pathogenic mechanisms involved in AD are diverse and thus it is difficult to recapitulate human AD in model organisms. Intracerebroventricular (ICV) injection of okadaic acid (OKA), a protein phosphatase 2A (PP2A) inhibitor, in rats causes neurotoxicity associated with neurofibrillary degeneration. However, this model lacks amyloid pathology as observed in AD. We aimed at combining two different treatments and hence producing a better animal model of AD which may mimic most of the neuropathological, neurobehavioral, and neurochemical changes observed in AD. For this, OKA (200 ng) was microinjected bilaterally into the hippocampus of male Wistar rats followed by exposure of same rats to hypoxic conditions (10%) for 3 days. The result of which, the combination model exhibited tau hyperphosphorylation along with Aβ upregulation as evident by western blotting and immunohistochemistry. The observed changes were accompanied with dysfunction of neurotransmitter system, i.e., decreased acetylcholine activity and expression. This combinatorial model also exhibited cognitive deficiency which was assessed by Morris water maze and avoidance tests along with enhanced oxidative stress which is thought to be a major player in AD pathogenesis. Taken together, we established an easily reproducible and reliable rat model for sporadic dementia of Alzheimer’s type in rats which allows effective testing of new therapeutic strategies.
KeywordsAlzheimer disease Amyloid beta Neurodegeneration Stereotaxic surgery Okadaic acid Hypoxia
Reactive oxygen species
Paired helical filament
This study was funded by Council of Scientific and Industrial Research (CSIR).
Compliance with Ethical Standards
Conflict of Interest
No conflicts of interest are declared by the authors.
- Areosa SA, Sherriff F (2003) Memantine for dementia Cochrane Database Syst Rev:CD003154Google Scholar
- Bromley-Brits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp 20:2920Google Scholar
- Forny-Germano L, Lyra e Silva NM, Batista AF, Brito-Moreira J, Gralle M, Boehnke SE, Coe BC, Lablans A, Marques SA, Martinez AMB, Klein WL, Houzel JC, Ferreira ST, Munoz DP, de Felice FG (2014) Alzheimer’s disease-like pathology induced by amyloid-beta oligomers in nonhuman primates. J Neurosci 34:13629–13643CrossRefGoogle Scholar
- Watson C, Paxinos G (2007) The rat brain in stereotaxic coordinates. Academic Press, San DiegoGoogle Scholar